首页> 外文OA文献 >The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

【2h】

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

机译：PROGENSA®前列腺癌抗原3测定法和前列腺健康指数在前列腺癌诊断中的临床有效性和成本效益：系统评价和经济评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nicholson, A; Mahon, J; Boland, A; Beale, S; Dwan, K; Fleeman, N; Hockenhull, J; Dundar, Y;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation [J] . Nicholson?A, Mahon?J, Boland?A, Health technology assessment: HTA . 2015,第87期

机译：PROGENSA＆＃174;的临床疗效和成本效益;前列腺癌抗原3检测和前列腺健康指数在前列腺癌诊断中的作用：系统评价和经济评价
2. Protocol for a systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer [J] . Health technology assessment: HTA . 2012,第41期

机译：对腹腔镜手术和机器人手术切除局部前列腺癌男性患者的相对临床收益和成本效益进行系统回顾和经济建模的协议
3. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer [J] . Health technology assessment: HTA . 2012,第41期

机译：腹腔镜手术和机器人手术切除局部前列腺癌男性相对临床利益和成本效益的系统评价和经济模型
4. Accurate Diagnosis for Prostate Cancer Measuring the Ratio between Two Types of Prostate Specific Antigens by LDI-TOF MS [C] . Minyoung Yoo, Woon-Seok Yeo ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：准确诊断前列腺癌测量通过LDI-TOF MS测量两种前列腺特异性抗原的比率
5. Mapping Expanded Prostate Cancer Index Composite (EPIC) Questionnaire to EuroQoL-5D (EQ-5D) Utility Weights to Inform Economic Evaluations for Prostate Cancer [D] . Khairnar, Rahul. 2020

机译：将扩大的前列腺癌指数复合（EPIC）问卷调查问卷到EUROQOL-5D（EQ-5D）实用权重，以便为前列腺癌提供经济评估
6. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. [O] . Amanda Nicholson, James Mahon, Angela Boland, -1

机译：PROGENSA®前列腺癌抗原3测定法和前列腺健康指数在前列腺癌诊断中的临床有效性和成本效益：系统评价和经济评估。
7. Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer [O] . 荒井陽一, 吉貴達寛, 岡田謙一郎, 1989

机译：血清前列腺特异性抗原在前列腺癌中的临床评估：前列腺特异性抗原，γ-半胱氨酸蛋白和前列腺酸磷酸酶的同时检测在113例前列腺癌患者中
8. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review. Comparative Effectiveness Review Number 146. [R] . 2014

机译：临床局限性前列腺癌的治疗：2008年系统评价的更新。比较效力审查编号146。

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

著录项

引文网络

相似文献

相关主题

期刊订阅